<DOC>
	<DOCNO>NCT00189995</DOCNO>
	<brief_summary>Aggressive , persistent aggression impulsive behavior frequently observe schizophrenic patient . According researcher `` 50 % psychiatric patient 10 % schizophrenic patient show aggressive symptom vary threaten behavior agitation assault '' ( 1 ) . It common cause psychiatric admission therapeutic issue . The treatment symptoms clinical problem patient staff . Violent behavior , major detrimental factor stigmatization mentally ill , also pose physical danger patient . Current pharmacotherapy pathologic aggression involve use multiple agent ( typical atypical antipsychotic , benzodiazepine , mood stabilizer , beta-blockers , antiandrogenic hormone , selective serotonin reuptake inhibitor ) empiric basis , vary degree response ( 2-6 ) . Unfortunately , approach lead numerous side effect . Poor noncompliance pharmacotherapy make difficult choose appropriate preparation . Currently , typical neuroleptic still first choice treat acute aggressive symptom , risperidone olanzapine could alternative ( 5-7 ) . Typical depot neuroleptic consider case medication compliance problem . Most clinical information treat aggression collect atypical neuroleptic , particularly regard clozapine . Clozapine indicate psychotic state and/or drug-resistant schizophrenic patient . According FDA - drug choice suicidal aggressive patient , due-to psychotic state . It find helpful nearly 30 % resistant schizophrenic patient . Concerning parenteral administration clozapine - little data available today . This study aim investigate efficacy safety ( psychopathology , side effect ) parenteral clozapine treatment aggressive behavior schizophrenic patient double-blind trial .</brief_summary>
	<brief_title>Clozapine IM Aggression Schizophrenic Patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Aggression</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<criteria>schizophrenic , schizoaffective , schizophreniform accord DSMIV treatmentresistant present pathologic violentaggressive behavior admission risk self damage age : 1865 patient participate study time study minimal score 70 PANSS prior resistance least 2 different class neuroleptic OAS score least 4 point physical aggression section least 2 point verbal aggression section neutropenia abnormal CBC result myeloproliferative disease chronic physical disease liver , renal cardiac disease history alcohol drug abuse history drug induce granulocytopenia/agranulocytosis alcoholic/drug psychosis intoxication carbamazepine bone marrow suppressor treatment uncontrolled epilepsy paralytic ileus hypersensitivity clozapine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2005</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>aggression</keyword>
	<keyword>clozapine</keyword>
	<keyword>efficacy</keyword>
	<keyword>double-blind</keyword>
</DOC>